Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Osanetant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cash-strapped Acer sees menopause drug flunk phase 2 trial
    Cash-strapped Acer sees menopause drug flunk phase 2 trial

    18 Mar 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cash-strapped-acer-sees-menopause-drug-flunk-phase-2-trial

    James Waldron FIERCE BIOTECH
    18 Mar 2023
    Share Share
    Acer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801
    Acer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801

    13 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/13/2606634/0/en/Acer-Therapeutics-Announces-Full-Enrollment-of-Phase-2a-Trial-of-ACER-801-Osanetant-for-Treatment-of-Moderate-to-Severe-Vasomotor-Symptoms-Associated-with-Menopause.html

    GLOBENEWSWIRE
    13 Feb 2023
    Share Share
    Acer Announces Initiation of Two Investigr-Sponsored Trials of ACER-801
    Acer Announces Initiation of Two Investigr-Sponsored Trials of ACER-801

    05 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/01/05/2583727/0/en/Acer-Therapeutics-Announces-Initiation-of-Two-Investigator-Sponsored-Trials-of-ACER-801-Osanetant-in-Men-with-Adenocarcinoma-of-the-Prostate.html

    GLOBENEWSWIRE
    05 Jan 2023
    Share Share
    Acer Announces University of NC Receives Department of Defense Grant ACER-801
    Acer Announces University of NC Receives Department of Defense Grant ACER-801

    06 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/06/2529532/0/en/Acer-Therapeutics-Announces-University-of-North-Carolina-Receives-Department-of-Defense-Grant-to-Support-the-Proposed-Investigator-Sponsored-OASIS-Trial-of-ACER-801-Osanetant-to-Re.html

    GLOBENEWSWIRE
    06 Oct 2022
    Share Share
    Acer Therapeutics Announces Expansion of ACER-801 (osanetant) DevP
    Acer Therapeutics Announces Expansion of ACER-801 (osanetant) DevP

    05 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/05/2528698/0/en/Acer-Therapeutics-Announces-Expansion-of-ACER-801-osanetant-Development-Indications-to-Include-Post-Traumatic-Stress-Disorder.html

    GLOBENEWSWIRE
    05 Oct 2022
    Share Share